(Press-News.org) At the 15th UN Biodiversity Conference (COP15) in Montreal, Canada, in 2022, nations committed to reducing the risks associated with pesticide use in agriculture by 50% by 2030. A new study by a research team from RPTUKaiserslautern-Landau, published in the journal Science, reveals that this global target is now under serious threat. Using a novel analytical method, the researchers assessed trends in pesticide toxicity worldwide and found that current trajectories fall far short of the 2030 goal. The study concludes that immediate, coordinated action across nearly all countries is essential to reverse the trend and meet the UN commitment.
The scientists analyzed global pesticide use data, comparing the amount of each active ingredient applied in agriculturewith its environmental toxicity. Using this approach, a research team led by environmental scientists Ralf Schulz and Jakob Wolfram developed a novel method to calculate applied toxicity – a measure of the annual environmental risk posed by pesticides in a country’s agricultural systems. This metric enables a more accurate assessment of the global threat or potential impacts pesticides pose to biodiversity. "This gives us a whole new perspective on the potential risks to the environment and biodiversity posed by pesticide use," emphasizes Ralf Schulz.
Key role: Global comparability of data
A major challenge in global analysis is ensuring consistent data quality across countries. To assess and compare risks globally, data must be available from as many nations as possible. The study used commercial application data that met these requirements, covering the period 2013 to 2019, aligning with the reference period (2010–2020) established by the UN biodiversity resolution. "To ensure continuous and comprehensive monitoring, it is essential that all countriesregularly report updated annual data on agricultural pesticide use, broken down by active ingredient. This would enable real-time tracking of progress toward the targets set at the UN Biodiversity Conference," says Jakob Wolfram.
The applied toxicity of pesticides has increased significantly
To calculate global applied toxicity, the study presents, for the first time, a comprehensive dataset of 625 pesticides. The dataset integrates data from seven major regulatory systems and covers the toxicity of eight organism groups used in pesticide approval processes. The results reveal a substantial increase in applied toxicity over the review period. "This rise is driven in part by higher pesticide amounts being applied – due to expanding farmland and intensified farming practices – and in part by the growing toxicity of the active ingredients themselves, particularly insecticides," says Ralf Schulz. The increases were particularly pronounced for land-dwelling insects, soil organisms, and fish. However, positive trends were also observed for aquatic invertebrates, pollinating insects, and terrestrial plants. Only two groups – aquatic plants and terrestrial vertebrates – showed declines. All major pesticide groups (herbicides, insecticides, and fungicides) contributed to the increase in applied toxicity, although only around 20 active ingredients were decisive for different animal and plant groups. According to the research team, these highly toxic substances should be prioritized for replacement with less toxic alternatives to better protect biodiversity. While case-specific solutions may be needed in some instances, the focus should be on phasing out the most harmful compounds.
Brazil, China, the USA, and India were the top contributors to global applied toxicity during the study period. In contrast, Nigeria showed comparatively low levels of applied toxicity. However, researchers warn this could change – even across Africa – as agricultural intensification accelerates and more toxic active ingredients are adopted. Globally, fruit, vegetables, corn, soybeans, cereals, and rice accounted for approximately 80% of total applied pesticide toxicity. "The interaction between cultivated land area and the types of crops grown is a key driver of applied toxicity and is thus another factor that can be adjusted in agricultural planning to achieve the goal of protecting biodiversity," emphasizes Jakob Wolfram. According to the research team, the trend of increasing applied toxicity, as calculated using comprehensive data, has probably continued. This is supported by data from the Food and Agriculture Organization of the United Nations (FAO), which reports a further increase in global pesticide use since 2019.
Comprehensive rethinking is required
Without immediate action, only Chile is projected to meet the UN's 2030 target. While China, Japan, and Venezuela showed a downward trend in applied toxicity during the observation period, most other countries, including Germany, must reverse their current trajectory. To achieve the target, Germany and similar nations will need to reduce applied pesticide toxicity to levels seen more than 15 years ago: "This can likely only be achieved by shifting to less toxic active ingredients and expanding the transition from conventional to organic agriculture, which would also deliver broader benefits for global biodiversity," emphasizes Jakob Wolfram.
The study:
Wolfram, J., Bussen, D., Bub, S., Petschick, L. L., Herrmann, L. Z., & Schulz, R. (2026). "Increasing applied pesticide toxicity trends counteract the global reduction target to safeguard biodiversity." Science. https://www.science.org/doi/10.1126/science.aea8602
END
Increasing pesticide toxicity threatens UN goal of global biodiversity protection by 2030
2026-02-05
ELSE PRESS RELEASES FROM THIS DATE:
How “invisible” vaccine scaffolding boosts HIV immune response
2026-02-05
LA JOLLA, CA—One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and antibodies. In most vaccines, HIV proteins are attached to a larger protein scaffolding that mimics a virus. Then, a person’s immune system produces a range of antibodies that recognize different bits of those proteins. Often, however, some of those antibodies react not to HIV itself—but to the scaffold used to deliver the vaccine.
Now, researchers at Scripps Research and the Massachusetts Institute of Technology (MIT) have developed a new kind ...
Study reveals the extent of rare earthquakes in deep layer below Earth’s crust
2026-02-05
Stanford researchers have created the first-ever global map of a rare earthquake type that occurs not in Earth’s crust but in our planet’s mantle, the layer sandwiched between the thin crust and Earth’s molten core. The new map will help scientists learn more about the mechanics of mantle earthquakes, in turn opening a window into the complexities and triggers for all earthquakes.
As reported in a study published Feb. 5 in Science, continental mantle earthquakes occur worldwide but are clustered regionally, particularly in the Himalayas in southern Asia and the ...
Boston College scientists help explain why methane spiked in the early 2020s
2026-02-05
Chestnut Hill, Mass (2/5/2026) – A combination of weakened atmospheric removal and increased emissions from warming wetlands, rivers, lakes, and agricultural land increased atmospheric methane at an unprecedented rate in the early 2020s, an international team of researchers report today in the journal Science.
A sharp decline in hydroxyl radicals – the primary “cleaning agent” that breaks down methane in the atmosphere – during 2020–2021 explains roughly 80 percent of the year-to-year variation in methane accumulation, according to the team, including Boston College Professor of Earth and Environmental Science Hanqin Tian.
At the same time, ...
Penn Nursing study identifies key predictors for chronic opioid use following surgery
2026-02-05
PHILADELPHIA (February 5, 2026) — For many Americans, a routine surgical procedure serves as their first introduction to opioid pain medication. While most stop using these drugs as they heal, a considerable number of "opioid-naïve" patients transition into New Persistent Opioid Use (NPOU)—continuing use long after the typical recovery period.
A new systematic review and meta-analysis led by Penn Nursing researchers, published in Pain Medicine, has identified the specific patient-related risk factors that most accurately predict which individuals are at the highest risk for this dangerous transition. The ...
KTU researcher’s study: Why Nobel Prize-level materials have yet to reach industry
2026-02-05
Excess carbon dioxide in the atmosphere, polluted water, and increasingly strict environmental regulations are driving the search for materials that can efficiently trap pollutants at the molecular level. For more than two decades, this challenge has drawn scientific attention to metal–organic frameworks (MOFs) – highly advanced porous materials widely regarded as one of the most promising tools for tackling climate change and environmental pollution.
The importance of this research field was recognised in 2025, when the Nobel Prize in Chemistry was awarded to the scientists who developed MOFs. Despite this recognition and their ...
Research spotlight: Interplay of hormonal contraceptive use, stress and cardiovascular risk in women
2026-02-05
Antonia Seligowski, PhD, of the Neurocardiac Effects of Stress & Trauma Laboratory within the Department of Psychiatry at Mass General Brigham, is the senior author of a paper published in JAMA Network Open, “Hormonal contraceptive use, stress disorders, and cardiovascular and thrombotic risk in women.”
Q: What challenges or unmet needs make this study important?
Over 400,000 women in the United States die each year from cardiovascular disease (CVD), the nation’s leading cause of death. Stress is a major risk factor for CVD, and stress‑related psychiatric disorders like anxiety and post-traumatic stress disorder ...
Pennington Biomedical’s Dr. Catherine Prater awarded postdoctoral fellowship from the American Heart Association
2026-02-05
BATON ROUGE, La. – Dr. Catherine Prater, postdoctoral researcher at Pennington Biomedical Research Center, has received a two-year fellowship from the American Heart Association. The fellowship includes a grant of more than $150,000 that will support research focused on weight gain markers. Her research project, “Examination of Metabolic Characteristics in the Predisposition for Weight Gain,” will reexamine existing clinical trial data with the goal of improving prediction ...
AI agents debate more effectively when given personalities and the ability to interrupt
2026-02-05
In a typical online meeting, humans don't always wait politely for their turn to speak. They interrupt to express strong agreement, stay silent when they are unsure, and let their personalities shape the flow of the discussion. Yet, when Artificial Intelligence (AI) agents are programmed to debate or collaborate, they are usually forced into a rigid, round-robin structure that stifles this natural dynamic.
Researchers from The University of Electro-Communications and the National Institute of Advanced Industrial Science and Technology (AIST) have demonstrated that allowing AI agents to break these rules can actually make them smarter.
Their new ...
Tenecteplase for acute non–large vessel occlusion 4.5 to 24 hours after ischemic stroke
2026-02-05
About The Study: Among patients with non–large vessel occlusion acute ischemic stroke and salvageable brain tissue, intravenous tenecteplase, a modified human tissue plasminogen activator, administered 4.5 to 24 hours after onset resulted in a greater likelihood of an excellent functional outcome at 90 days than standard care but had an increased risk of symptomatic intracranial hemorrhage.
Corresponding Author: To contact the corresponding author, Junwei Hao, MD, PhD, email haojunwei@vip.163.com.
To ...
Immune 'hijacking' predicts cancer evolution
2026-02-05
Predicting tumour progression is one of the major challenges in oncology. Scientists at the University of Geneva (UNIGE) and the Ludwig Institute for Cancer Research have discovered that neutrophils, a type of immune cell, undergo reprogramming when they come into contact with the tumour ecosystem and contribute to its progression. They then produce a molecule — the chemokine CCL3 — which promotes cancer growth rather than fighting it. This mechanism appears to be a major variable in tumour biology and could serve ...